Serum sodium disorders in patients with traumatic brain injury
Nenhuma Miniatura disponível
Citações na Scopus
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Citação
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, v.7, p.345-349, 2011
Resumo
Sodium disorders are the most common and most poorly understood electrolyte disorders in neurological patients. The aim of this study was to determine the incidence of sodium disorders and its association with different traumatic brain injuries. This prospective study was conducted in 80 patients diagnosed with moderate and severe traumatic brain injuries. All patients underwent cerebral computed tomography. Incidence of sodium disorders, presence of injuries in the first computed tomography after traumatic brain injury, and level of consciousness were analyzed. Patients that presented other potential causes of sodium disorders and systemic trauma were excluded from the study. The incidence of sodium disturbances was 45%: 20 patients presented hypernatremia and 16 hyponatremia. Refers to all patients with sodium disturbances 53% were detected in the first sample. We recorded at least one measurement <125 mEq/L in 50% of the patients with hyponatremia. A greater incidence of sodium disorders was found in patients with subdural, intracerebral hematoma and with diffuse axonal injury. The incidence of sodium disorders among the patients with diffuse lesions was greater than in the group of patients with brain contusion (P = 0.022). The incidence of sodium disorders is higher in patients with diffuse traumatic brain injuries. No association was found between focal lesions and proportion of sodium disorders. Keywords: brain trauma, hypernatremia, hyponatremia
Palavras-chave
brain trauma, hypernatremia, hyponatremia
Referências
- MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146
- TEASDALE G, 1974, LANCET, V2, P81
- Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035
- WIJDICKS EFM, 1991, STROKE, V22, P1519
- Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819
- SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0
- Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x
- STERNS RH, 1987, ANN INTERN MED, V107, P656
- Donati-Genet PCM, 2001, J PEDIATR SURG, V36, P1094, DOI 10.1053/jpsu.2001.24770
- ARIEFF AI, 1992, BRIT MED J, V304, P1218
- Belvins LS, 1992, CRIT CARE MED, V20, P69
- Coenraad MJ, 2003, EUR J INTERN MED, V14, P302, DOI 10.1016/S0953-6205(03)00100-6
- DIRINGER MN, 1991, STROKE, V22, P577
- Doc ZIT, 1981, NEUROSURGERY, V9, P394
- Goldsmith M F, 1987, JAMA, V257, P287, DOI 10.1001/jama.257.3.287
- Horn LJ, 1982, J HEAD TRAUMA REHAB, V3, P86
- Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953
- Marshall LF, 1991, J NEUROSURG S, V75, P14
- Mizobata Y, 2001, J TRAUMA, V50, P871, DOI 10.1097/00005373-200105000-00016
- Revilla-Pacheco FR, 2005, NEUROL RES, V27, P418, DOI 10.1179/016164105X17152
- RICHARDS AM, 1985, HYPERTENSION, V7, P812
- Taikkanen I, 1986, J CLIN INVEST, V77, P734